Showing results (1511-1520 of 3,072) with videos related to

Sort By:
Pageof 308
Chemotherapy|October 13, 2024
Therapeutic Drug Monitoring of Imatinib: Is There a Rationale for Also Quantifying Its Active Metabolite?Clara Eschalier, Thierry Lafont, Sabrina Marsili, et al.
Chemotherapy|May 25, 2025
Carnitine Levels Decrease during Oxaliplatin Infusion: A Pilot StudyLianne P W van Geffen, Floortje Mols, Veerle C M Geurts, et al.
Chemotherapy|June 10, 2024
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center ExperienceEdy Ippolito, Francesco Pantano, Sonia Silipigni, et al.
Chemotherapy|June 29, 2026
Beyond Conventional Monoclonals: Novel Antibody Formats and Derivatives as the Next Frontier in Cancer TherapyRossana Roncato, Diletta Pasin, Emanuela Dell Apos Aquila, et al.
Chemotherapy|July 30, 2003
Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidisKyong Ran Peck, Shin Woo Kim, Sook-In Jung, et al.
Chemotherapy|July 30, 2003
Combination chemotherapy with irinotecan and ifosfamide as second-line treatment of refractory or sensitive relapsed small cell lung cancer: a phase II studyMasao Ichiki, Rumi Gohara, Toru Rikimaru, et al.
Chemotherapy|July 30, 2003
Lung, pleural and colon actinomycosis in an immunocompromised patient: a rare form of presentationK Charalabopoulos, A K Charalabopoulos, V Papalimneou, et al.
Chemotherapy|January 1, 1992
Exposure effects of netilmicin on Enterobacter cloacae clinical isolatesL S Tzouvelekis, A F Mentis, E Tzelpi, et al.
Chemotherapy|January 1, 1992
Randomized comparison of ceftriaxone versus ceftriaxone plus amikacin for the empirical treatment of infections in patients with altered host defense: microbiological and clinical evaluationD D'Antonio, G Fioritoni, A Iacone, et al.
Chemotherapy|January 1, 1992
In vitro activity of sparfloxacin and other antimicrobial agents against genital pathogensJ C Lefèvre, R Bauriaud, E Gaubert, et al.
Pageof 308